EUVIMEDEUVIMED entdecken
Open Access

Arrestin‐3 binds parkin and enhances parkin‐dependent mitophagy

Chen Zheng, Kevin K Nguyen, Sergey A Vishnivetskiy, Vsevolod V Gurevich iD, Eugenia V Gurevich iD

Journal of Neurochemistry · 2025

DOI: 10.1111/jnc.16043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurochemistry, 2025. Verfasst von Chen Zheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Vanderbilt University, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Mitophagy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NEI NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Arrestins were discovered for their role in homologous desensitization of G‐protein‐coupled receptors (GPCRs). Later non‐visual arrestins were shown to regulate several signaling pathways. Some of these pathways require arrestin binding to GPCRs, the regulation of others is receptor independent. Here, we demonstrate that arrestin‐3 binds the E3 ubiquitin ligase parkin via multiple sites, preferentially interacting with its RING0 domain. Identification of the parkin domains involved suggests that arrestin‐3 likely relieves parkin autoinhibition and/or stabilizes the enzymatically active “open” conformation of parkin. Arrestin‐3 binding enhances ubiquitination by parkin of the mitochondrial protein mitofusin‐1 and facilitates parkin‐mediated mitophagy in HeLa cells. Furthermore, arrestin‐3 and its mutant with enhanced parkin binding rescue mitofusin‐1 ubiquitination and mitophagy in the presence of the Parkinson's disease‐associated R275W parkin mutant, which is defective in both functions. Thus, modulation of parkin activity via arrestin‐3 might be a novel strategy of anti‐parkinsonian therapy. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ubiquitin-Protein LigasesMitophagyHumansHeLa CellsArrestinsProtein BindingHEK293 CellsUbiquitinationGTP Phosphohydrolases

Stichwörter der Autor:innen

arrestinmitochondriamitophagyparkin

Substanzen

Ubiquitin-Protein Ligasesparkin proteinarrestin3ArrestinsGTP Phosphohydrolases

Autor:innen und Institutionen

  • Department of Pharmacology, Vanderbilt University, Nashville, Tennessee, USA.

ORCID-Profile: Vsevolod V Gurevich, Eugenia V Gurevich

Förderung

  • NIGMS NIH HHS
  • NEI NIH HHS
  • NCI NIH HHS
  • NIDDK NIH HHS
  • National Institute of General Medical Sciences
  • National Eye Institute

Zitieren

APA

Zheng, C., Nguyen, K. K., Vishnivetskiy, S. A., Gurevich, V. V., & Gurevich, E. V. (2025). Arrestin‐3 binds parkin and enhances parkin‐dependent mitophagy. Journal of Neurochemistry. https://doi.org/10.1111/jnc.16043

Vancouver

Zheng C, Nguyen KK, Vishnivetskiy SA, Gurevich VV, Gurevich EV. Arrestin‐3 binds parkin and enhances parkin‐dependent mitophagy. Journal of Neurochemistry. 2025. doi:10.1111/jnc.16043

BibTeX
@article{Zheng2025,
  author = {Zheng, Chen and Nguyen, Kevin K and Vishnivetskiy, Sergey A and Gurevich, Vsevolod V and Gurevich, Eugenia V},
  title = {Arrestin‐3 binds parkin and enhances parkin‐dependent mitophagy},
  journal = {Journal of Neurochemistry},
  year = {2025},
  doi = {10.1111/jnc.16043}
}
Kostenlos starten →